United States Biotechnology & Medical Research

Pfenex Inc (PFNX)

Track

Pfenex Inc. has recorded no insider trading activity within the last three months. The most recent transaction occurred on June 16, 2020, involving a planned sale of shares by the Chief Business Officer. Historical data indicates a pattern of periodic divestments by executives, with no significant buying interest observed in recent years.
Ticker: PFNX Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Lucy Patrick K. Chief Business Officer Officer
Transaction date
Planned sale
Price
438.92
Quantity 6,891 -27.4%
Value US$4,875,410
Lucy Patrick K. Chief Business Officer Officer
Transaction date
Planned sale
Price
290.74
Quantity 44,734 -15.8%
Value US$3,178,300
Lucy Patrick K. Chief Business Officer
Transaction date
Planned sale
Price
411.80
Quantity 52,901 -32.5%
Value US$3,960,547
Lucy Patrick K. Chief Business Officer
Transaction date
Planned sale
Price
10.01
Quantity 250 -0.3%
Value US$2,502
Lucy Patrick K. Chief Business Officer
Transaction date
Planned sale
Price
10.00
Quantity 1,800 -1.9%
Value US$18,000
Lucy Patrick K. Chief Business Officer
Transaction date
Planned sale
Price
10.01
Quantity 3,950 -4.0%
Value US$39,532
Lucy Patrick K. Chief Business Officer
Transaction date
Planned sale
Price
8.00
Quantity 6,000 -5.7%
Value US$48,021
SCHNEIDER PHILLIP M Non-Executive Director
Transaction date
Purchase
Price
4.99
Quantity 11,000 +inf%
Value US$54,890
Schimmelpennink Evert B. See Remarks Executive Director
Transaction date
Purchase
Price
5.01
Quantity 500 +1.9%
Value US$2,505
Schimmelpennink Evert B. See Remarks Executive Director
Transaction date
Purchase
Price
5.04
Quantity 9,500 +57.0%
Value US$47,880
Campbell Robin Non-Executive Director
Transaction date
Purchase
Price
4.85
Quantity 5,000 +inf%
Value US$24,272
Grenfell-Gardner Jason
Transaction date
Purchase
Price
4.51
Quantity 10,000 +inf%
Value US$45,058
Lady Patricia Chief Accounting Officer Officer
Transaction date
Sale
Price
4.78
Quantity 2,000 -36.4%
Value US$9,569
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.50
Quantity 98 -0.0%
Value US$931
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.50
Quantity 302 -0.0%
Value US$2,869
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.51
Quantity 342 -0.1%
Value US$3,253
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.51
Quantity 1,049 -0.1%
Value US$9,977
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.50
Quantity 1,554 -0.3%
Value US$14,765
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.50
Quantity 4,765 -0.3%
Value US$45,273
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.65
Quantity 517 -0.1%
Value US$4,989
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.65
Quantity 1,587 -0.1%
Value US$15,316
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.66
Quantity 5,410 -1.0%
Value US$52,240
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.66
Quantity 16,590 -1.0%
Value US$160,196
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.67
Quantity 6,664 -1.2%
Value US$64,441
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.67
Quantity 20,436 -1.2%
Value US$197,616
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.55
Quantity 19,058 -3.2%
Value US$182,004
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.55
Quantity 58,442 -3.2%
Value US$558,121
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.58
Quantity 275 -0.0%
Value US$2,634
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.58
Quantity 845 -0.0%
Value US$8,095
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.61
Quantity 2,404 -0.4%
Value US$23,102
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
9.61
Quantity 7,372 -0.4%
Value US$70,845
Lady Patricia Chief Accounting Officer Officer
Transaction date
Sale
Price
9.87
Quantity 2,000 -41.7%
Value US$19,736
Lucy Patrick K. Chief Business Officer Officer
Transaction date
Planned sale
Price
10.04
Quantity 5,000 -4.7%
Value US$50,208
Lady Patricia Chief Accounting Officer Officer
Transaction date
Sale
Price
9.42
Quantity 2,000 -41.7%
Value US$18,836
Lady Patricia Chief Accounting Officer Officer
Transaction date
Sale
Price
6.52
Quantity 2,000 -48.8%
Value US$13,043
DOW CHEMICAL CO /DE/ Large shareholder
Transaction date
Sale
Price
11.75
Quantity 600,000 -21.3%
Value US$7,050,000
Liang Bertrand C. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.56
Quantity 200 -0.0%
Value US$3,112
Lady Patricia Chief Accounting Officer Officer
Transaction date
Sale
Price
14.05
Quantity 2,000 -58.8%
Value US$28,101
Lucy Patrick K. Chief Business Officer Officer
Transaction date
Planned sale
Price
18.05
Quantity 200 -0.2%
Value US$3,609
Lady Patricia Chief Accounting Officer Officer
Transaction date
Planned sale
Price
20.48
Quantity 2,000 -58.8%
Value US$40,960
Liang Bertrand C. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
21.78
Quantity 300 -0.1%
Value US$6,534
Liang Bertrand C. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
20.28
Quantity 200 -0.0%
Value US$4,055
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
14.57
Quantity 330,959 -35.8%
Value US$4,822,073
GALE JAMES C Non-Executive Director
Transaction date
Sale
Price
14.57
Quantity 330,959 -35.8%
Value US$4,822,073
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
14.57
Quantity 1,576,808 -46.4%
Value US$22,974,093
GALE JAMES C Non-Executive Director
Transaction date
Sale
Price
14.57
Quantity 1,576,808 -46.4%
Value US$22,974,093
DOW CHEMICAL CO /DE/ Large shareholder
Transaction date
Sale
Price
14.57
Quantity 960,194 -100.0%
Value US$13,990,027
DOW CHEMICAL CO /DE/ Large shareholder
Transaction date
Sale
Price
14.57
Quantity 1,272,039 -31.1%
Value US$18,533,608
Liang Bertrand C. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.97
Quantity 400 -0.1%
Value US$6,389
GALE JAMES C Non-Executive Director
Transaction date
Sale
Price
0.31
Quantity 299,392 -8.1%
Value US$92,812
GALE JAMES C Non-Executive Director
Transaction date
Sale
Price
0.31
Quantity 81,475 -8.1%
Value US$25,257
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
0.31
Quantity 299,392 -8.1%
Value US$92,812
SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
Transaction date
Sale
Price
0.31
Quantity 81,475 -8.1%
Value US$25,257
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-06-17 2020-06-16 PlS Planned sale
Lucy Patrick K.

Chief Business Officer

Officer
6,891 -27.4%
438.92
US$4,875,410 		6,891 -27.4% 438.92 US$4,875,410
2020-03-03 2020-03-02 PlS Planned sale
Lucy Patrick K.

Chief Business Officer

Officer
44,734 -15.8%
290.74
US$3,178,300 		44,734 -15.8% 290.74 US$3,178,300
2019-11-27 2019-11-27 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
52,901 -32.5%
411.80
US$3,960,547 		52,901 -32.5% 411.80 US$3,960,547
2019-09-16 2019-09-16 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
250 -0.3%
10.01
US$2,502 		250 -0.3% 10.01 US$2,502
2019-09-16 2019-09-16 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
1,800 -1.9%
10.00
US$18,000 		1,800 -1.9% 10.00 US$18,000
2019-09-16 2019-09-13 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
3,950 -4.0%
10.01
US$39,532 		3,950 -4.0% 10.01 US$39,532
2019-09-10 2019-09-06 PlS Planned sale
Lucy Patrick K.

Chief Business Officer
6,000 -5.7%
8.00
US$48,021 		6,000 -5.7% 8.00 US$48,021
2018-09-13 2018-09-11 B Purchase SCHNEIDER PHILLIP M Non-Executive Director
11,000 +inf%
4.99
US$54,890 		11,000 +inf% 4.99 US$54,890
2018-09-13 2018-09-11 B Purchase Schimmelpennink Evert B.

See Remarks

Executive Director
500 +1.9%
5.01
US$2,505 		500 +1.9% 5.01 US$2,505
2018-09-13 2018-09-11 B Purchase Schimmelpennink Evert B.

See Remarks

Executive Director
9,500 +57.0%
5.04
US$47,880 		9,500 +57.0% 5.04 US$47,880
2018-08-24 2018-08-22 B Purchase Campbell Robin Non-Executive Director
5,000 +inf%
4.85
US$24,272 		5,000 +inf% 4.85 US$24,272
2017-06-12 2017-06-12 B Purchase Grenfell-Gardner Jason
10,000 +inf%
4.51
US$45,058 		10,000 +inf% 4.51 US$45,058
2017-05-17 2017-05-16 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -36.4%
4.78
US$9,569 		2,000 -36.4% 4.78 US$9,569
2017-01-10 2017-01-06 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
98 -0.0%
9.50
US$931 		98 -0.0% 9.50 US$931
2017-01-10 2017-01-06 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
302 -0.0%
9.50
US$2,869 		302 -0.0% 9.50 US$2,869
2017-01-06 2017-01-05 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
342 -0.1%
9.51
US$3,253 		342 -0.1% 9.51 US$3,253
2017-01-06 2017-01-05 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,049 -0.1%
9.51
US$9,977 		1,049 -0.1% 9.51 US$9,977
2017-01-06 2017-01-04 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,554 -0.3%
9.50
US$14,765 		1,554 -0.3% 9.50 US$14,765
2017-01-06 2017-01-04 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
4,765 -0.3%
9.50
US$45,273 		4,765 -0.3% 9.50 US$45,273
2016-12-30 2016-12-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
517 -0.1%
9.65
US$4,989 		517 -0.1% 9.65 US$4,989
2016-12-30 2016-12-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,587 -0.1%
9.65
US$15,316 		1,587 -0.1% 9.65 US$15,316
2016-12-30 2016-12-28 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
5,410 -1.0%
9.66
US$52,240 		5,410 -1.0% 9.66 US$52,240
2016-12-30 2016-12-28 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
16,590 -1.0%
9.66
US$160,196 		16,590 -1.0% 9.66 US$160,196
2016-12-28 2016-12-27 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
6,664 -1.2%
9.67
US$64,441 		6,664 -1.2% 9.67 US$64,441
2016-12-28 2016-12-27 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
20,436 -1.2%
9.67
US$197,616 		20,436 -1.2% 9.67 US$197,616
2016-12-28 2016-12-23 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
19,058 -3.2%
9.55
US$182,004 		19,058 -3.2% 9.55 US$182,004
2016-12-28 2016-12-23 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
58,442 -3.2%
9.55
US$558,121 		58,442 -3.2% 9.55 US$558,121
2016-12-23 2016-12-22 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
275 -0.0%
9.58
US$2,634 		275 -0.0% 9.58 US$2,634
2016-12-23 2016-12-22 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
845 -0.0%
9.58
US$8,095 		845 -0.0% 9.58 US$8,095
2016-12-23 2016-12-21 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
2,404 -0.4%
9.61
US$23,102 		2,404 -0.4% 9.61 US$23,102
2016-12-23 2016-12-21 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
7,372 -0.4%
9.61
US$70,845 		7,372 -0.4% 9.61 US$70,845
2016-11-22 2016-11-21 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -41.7%
9.87
US$19,736 		2,000 -41.7% 9.87 US$19,736
2016-11-15 2016-11-15 PlS Planned sale Lucy Patrick K.

Chief Business Officer

Officer
5,000 -4.7%
10.04
US$50,208 		5,000 -4.7% 10.04 US$50,208
2016-08-18 2016-08-18 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -41.7%
9.42
US$18,836 		2,000 -41.7% 9.42 US$18,836
2016-05-25 2016-05-24 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -48.8%
6.52
US$13,043 		2,000 -48.8% 6.52 US$13,043
2015-12-17 2015-12-15 S Sale DOW CHEMICAL CO /DE/ Large shareholder
600,000 -21.3%
11.75
US$7,050,000 		600,000 -21.3% 11.75 US$7,050,000
2015-12-02 2015-12-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
200 -0.0%
15.56
US$3,112 		200 -0.0% 15.56 US$3,112
2015-11-19 2015-11-18 S Sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -58.8%
14.05
US$28,101 		2,000 -58.8% 14.05 US$28,101
2015-11-05 2015-11-04 PlS Planned sale Lucy Patrick K.

Chief Business Officer

Officer
200 -0.2%
18.05
US$3,609 		200 -0.2% 18.05 US$3,609
2015-09-04 2015-09-03 PlS Planned sale Lady Patricia

Chief Accounting Officer

Officer
2,000 -58.8%
20.48
US$40,960 		2,000 -58.8% 20.48 US$40,960
2015-09-02 2015-09-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
300 -0.1%
21.78
US$6,534 		300 -0.1% 21.78 US$6,534
2015-07-02 2015-07-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
200 -0.0%
20.28
US$4,055 		200 -0.0% 20.28 US$4,055
2015-04-30 2015-04-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
330,959 -35.8%
14.57
US$4,822,073 		330,959 -35.8% 14.57 US$4,822,073
2015-04-30 2015-04-29 S Sale GALE JAMES C Non-Executive Director
330,959 -35.8%
14.57
US$4,822,073 		330,959 -35.8% 14.57 US$4,822,073
2015-04-30 2015-04-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
1,576,808 -46.4%
14.57
US$22,974,093 		1,576,808 -46.4% 14.57 US$22,974,093
2015-04-30 2015-04-29 S Sale GALE JAMES C Non-Executive Director
1,576,808 -46.4%
14.57
US$22,974,093 		1,576,808 -46.4% 14.57 US$22,974,093
2015-04-29 2015-04-29 S Sale DOW CHEMICAL CO /DE/ Large shareholder
960,194 -100.0%
14.57
US$13,990,027 		960,194 -100.0% 14.57 US$13,990,027
2015-04-29 2015-04-29 S Sale DOW CHEMICAL CO /DE/ Large shareholder
1,272,039 -31.1%
14.57
US$18,533,608 		1,272,039 -31.1% 14.57 US$18,533,608
2015-04-02 2015-04-01 PlS Planned sale Liang Bertrand C.

Chief Executive Officer

Executive Director
400 -0.1%
15.97
US$6,389 		400 -0.1% 15.97 US$6,389
2014-07-31 2014-07-29 S Sale GALE JAMES C Non-Executive Director
299,392 -8.1%
0.31
US$92,812 		299,392 -8.1% 0.31 US$92,812
2014-07-31 2014-07-29 S Sale GALE JAMES C Non-Executive Director
81,475 -8.1%
0.31
US$25,257 		81,475 -8.1% 0.31 US$25,257
2014-07-30 2014-07-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
299,392 -8.1%
0.31
US$92,812 		299,392 -8.1% 0.31 US$92,812
2014-07-30 2014-07-29 S Sale SIGNET HEALTHCARE PARTNERS ACCREDITED PARTNERSHIP III LP Large shareholder
81,475 -8.1%
0.31
US$25,257 		81,475 -8.1% 0.31 US$25,257
Explore more

More insider trading research around Pfenex Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America